Giant cell myositis associated with metastatic thymoma and granulomatous hypercalcaemia

Giant cell myositis (GCM) is a rare inflammatory myopathy associated with myasthenia gravis and thymoma. Here, we report on a woman in her late 50s with a history of myasthenia gravis, systemic lupus erythematosus and stage IV thymoma with pleural metastases, who presented with proximal weakness, neuromuscular respiratory failure and hypercalcaemia. She was diagnosed with GCM via muscle biopsy and screened for myocarditis but showed no evidence of myocardial involvement. Her hypercalcaemia was consistent with a granulomatous process, likely driven by her GCM. Her strength gradually improved, and her hypercalcaemia did not recur after treatment with high dose steroids, intravenous immune globulin and plasma exchange. Her course was complicated by several opportunistic infections in the setting of her immunosuppression. Despite the high morbidity associated with GCM, she demonstrated clinical improvement after initiating immunosuppressive therapy and continues to be managed in the outpatient setting.

[1]  R. Kalish,et al.  Giant cell myositis associated with concurrent myasthenia gravis: a case-based review of the literature , 2021, Clinical Rheumatology.

[2]  P. Oflazer Giant cell myositis and myocarditis revisited , 2020, Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology.

[3]  M. Ried,et al.  Classification and staging of thymoma , 2020, Journal of thoracic disease.

[4]  S. Birring,et al.  A review of the musculoskeletal manifestations of sarcoidosis , 2018, Rheumatology.

[5]  S. Otto,et al.  Infections and vaccinations as possible triggers of inflammatory myopathies , 2017, Muscle & nerve.

[6]  M. Aletti,et al.  Hypercalcemia revealing diffuse granulomatous myositis , 2017, European Journal of Nuclear Medicine and Molecular Imaging.

[7]  U. Ziemann,et al.  A case of late-onset, thymoma-associated myasthenia gravis with ryanodine receptor and titin antibodies and concomitant granulomatous myositis , 2016, BMC Neurology.

[8]  T. Maisonobe,et al.  Life-Threatening Hypercalcemia Revealing Diffuse and Isolated Acute Sarcoid-Like Myositis , 2016, Medicine.

[9]  J. Smolle,et al.  Stage-based treatment for thymoma in due consideration of thymectomy: a single-center experience and comparison with the literature , 2015, World Journal of Surgical Oncology.

[10]  D. Hilton,et al.  Giant cell myositis responsive to combined corticosteroids and immunoglobulin , 2015, Practical Neurology.

[11]  W. Fang,et al.  Giant cell polymyositis associated with myasthenia gravis and thymoma , 2014, Journal of Clinical Neuroscience.

[12]  L. Negrão,et al.  Macrophagic myofasciitis and vaccination: Consequence or coincidence? , 2014, Rheumatology International.

[13]  J. Tomaszewski,et al.  Hypercalcemia Due to Giant Cell Myocarditis: A Case Report , 2013, Progress in transplantation.

[14]  A. Engel,et al.  Teaching NeuroImages: Hydroxychloroquine-induced vacuolar myopathy , 2013, Neurology.

[15]  K. Wakabayashi,et al.  Giant cell polymyositis and myocarditis associated with myasthenia gravis and thymoma , 2013, Neuropathology : official journal of the Japanese Society of Neuropathology.

[16]  H. Sasaki,et al.  Thymoma associated with fatal myocarditis and polymyositis in a 58-year-old man following treatment with carboplatin and paclitaxel: A case report. , 2012, Oncology letters.

[17]  Y. Shoenfeld,et al.  'ASIA' - autoimmune/inflammatory syndrome induced by adjuvants. , 2011, Journal of autoimmunity.

[18]  F. Green,et al.  Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review. , 2010, The Journal of clinical endocrinology and metabolism.

[19]  H. Orbach,et al.  Vaccines as a trigger for myopathies , 2009, Lupus.

[20]  E. Fadel,et al.  Fatal giant cell myocarditis after thymoma resection in myasthenia gravis. , 2006, The Journal of thoracic and cardiovascular surgery.

[21]  J. Bilezikian,et al.  Rare causes of hypercalcemia , 2005 .

[22]  J. Bilezikian,et al.  Clinical review: Rare causes of hypercalcemia. , 2005, The Journal of clinical endocrinology and metabolism.

[23]  S. Nogawa,et al.  A case report of giant cell myocarditis and myositis observed during the clinical course of invasive thymoma associated with myasthenia gravis. , 2004, The Keio journal of medicine.

[24]  R. Gherardi,et al.  [Lessons from macrophagic myofasciitis: towards definition of a vaccine adjuvant-related syndrome]. , 2003, Revue neurologique.

[25]  F. Authier,et al.  Macrophagic myofasciitis lesions assess long-term persistence of vaccine-derived aluminium hydroxide in muscle. , 2001, Brain : a journal of neurology.

[26]  G. Berry,et al.  Idiopathic giant-cell myocarditis--natural history and treatment. Multicenter Giant Cell Myocarditis Study Group Investigators. , 1997, The New England journal of medicine.

[27]  M. Sheppard,et al.  Fatal giant cell myocarditis after resection of thymoma. , 1996, Heart.

[28]  Y. Monden,et al.  Follow‐up study of thymomas with special reference to their clinical stages , 1981, Cancer.

[29]  W. Ehrengut DERMATOMYOSITIS AND VACCINATION , 1978, The Lancet.